del Pozo-Rubio, Raúl
Ortega-Ortega, Marta
Funding for this research was provided by:
XXXIII Edition Grant Spanish Association of Health Economics and Bayer HealthCare
Spanish State Programme of R+D+I (R+D+I ECO2017-83771-C3-1-R.)
Article History
Received: 23 September 2021
Accepted: 24 February 2022
First Online: 9 March 2022
Declarations
:
: The Clinical Research Ethics Committee and Haematology Department of each health centre, the University Hospital Virgen de las Nieves in Granada (Spain) and the University Hospital Virgen del Rocio in Seville (Spain), approved the study. Also, both hospitals are reference hospitals for malignant haematological diseases in southeast and southwest Spain, respectively. Also, written informed consent was obtained from every patient interviewed for publication. A copy of the written consent is available for review by the Editor-in-Chief of this journal on request.
: This manuscript is an original work and has been done by the authors, RPR and MOO who all are aware of its content and approve its submission. This manuscript has not been published elsewhere in part or in entirety, and is not under consideration by another journal. All authors gave their consent for publication in The European Journal of Health Economics.
: The authors of this manuscript have no conflicts of interest.